Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3035% below fair value
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $9.63MP/E –Yield –
Femasys free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Femasys's free cash flow for the twelve months ending Jun 30, 2026 was -$18.07M. For fiscal 2025 it was -$19.22M. The highest annual figure on record is -$4.94M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.22M | – |
| FY2024 | Dec 31, 2024 | -$20.21M | – |
| FY2023 | Dec 31, 2023 | -$11.42M | – |
| FY2022 | Dec 31, 2022 | -$11.14M | – |
| FY2021 | Dec 31, 2021 | -$8.24M | – |
| FY2020 | Dec 31, 2020 | -$4.94M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.95M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.22M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.45M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.86M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.88M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.51M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.63M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.08M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.88M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.96M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.75M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.55M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.73M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$862.33K | – |
See a number that looks wrong?